Targeting the LPA1 signaling pathway for fibrosis therapy: a patent review (2010-present)

Gu, ZH; Yan, Y; Yao, HQ; Lin, KJ; Li, XY

Yao, HQ; Lin, KJ; Li, XY (通讯作者),China Pharmaceut Univ, Sch Pharm, Nanjing 210009, Peoples R China.

EXPERT OPINION ON THERAPEUTIC PATENTS, 2022; 32 (10): 1097

Abstract

Introduction Fibrosis is a disease that damages organs and even causes death. Because of the complicated pathogenesis, the development of drugs for fi......

Full Text Link